2X Makes Strategic Investment in Get Levrg to Expand Scalable Marketing-as-a-Service Solutions

MALVERN, Pa., Jan. 21, 2025 (GLOBE NEWSWIRE) — 2X, the leader in marketing as a service (MaaS), today announced a strategic investment in Get Levrg, a subscription-based service provider delivering tailored go-to-market (GTM) solutions for start-ups, founder-led, and venture-backed businesses. This investment extends 2X's proven enterprise frameworks and tools to smaller organizations, enabling them to […]

Tive & BioPharma Dive Reveal How Pharma Leaders Combat Rising Supply Chain Risks with Visibility Technology

BOSTON, Jan. 21, 2025 (GLOBE NEWSWIRE) — Tive, the global leader in supply chain and logistics visibility technology, today announced the results of a groundbreaking survey–“How Pharma Supply Chain Leaders are Mitigating Rising Security Risks with Visibility Technology“–conducted in partnership with BioPharma Dive's studioID. More than 100 pharmaceutical, biologics, and medical device manufacturing executives were

FASTEST GROWING BRANDS TO WATCH IN 2025 – RANKINGS RELEASED BY NUMERATOR

CHICAGO, Jan. 21, 2025 (GLOBE NEWSWIRE) — Numerator, a data and tech company serving the market research space, has released its rankings of Brands to Watch in 2025. The list leverages proprietary Numerator consumer data, including survey, psychographics, and purchase metrics, to identify brands expected to experience significant growth in the coming year. A blended

Shuttle Pharma Reaches Milestone in Patient Enrollment for Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma

(NASDAQ:SHPH), GAITHERSBURG, Md., Jan. 21, 2025 (GLOBE NEWSWIRE) — Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma”), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer patients treated with radiation therapy (RT), announced today that it has achieved 25% enrollment in the initial randomized portion of its Phase 2 Clinical

Muscular Dystrophy Association’s Legacy Awards Honor Pioneers in Clinical Research and Community Impact at 2025 MDA Clinical & Scientific Conference in March

New York, Jan. 21, 2025 (GLOBE NEWSWIRE) — The Muscular Dystrophy Association (MDA) is proud to announce that Katherine Mathews, MD, a renowned leader in genetic medicine and pediatric neurology at the University of Iowa, will be honored with the 2025 MDA Legacy Award for Achievement in Clinical Research. Additionally, Donavon Decker, the first muscular

Welcoming Victor Bornsztejn as Senior Vice President of Commercial

SAN FRANCISCO, CALIFORNIA, UNITED STATES, Jan. 21, 2025 (GLOBE NEWSWIRE) — Culture Biosciences, a leader in cloud-connected bioprocessing technologies, is pleased to announce the appointment of Victor Bornsztejn as the company's new Senior Vice President of Commercial. In this strategic role, Victor will oversee the commercial direction of the company and lead the launch of

ConnectWise Announces Strategic Leadership Appointments to Drive Growth and Innovation

TAMPA, Fla., Jan. 21, 2025 (GLOBE NEWSWIRE) — ConnectWise, the world's leading software company dedicated to the success of managed service providers (MSPs), today announced key leadership appointments to further its mission of empowering technology teams and driving innovation across the industry. The new leadership roles position ConnectWise for continued success, with a focus on

Chatmeter Launches Industry First AI-Powered Review Image Analysis Tool and Introduces Review Generation to Help Multi-Location Businesses Build Trusted Reputations

SAN DIEGO, Jan. 21, 2025 (GLOBE NEWSWIRE) — Chatmeter, the leader in multi-location customer intelligence, today introduced new capabilities to its all-in-one reputation management platform, Pulse Ai. Pulse Ai: Signals can now analyze photos in reviews and surface photos relevant to customer feedback trends-an industry first. Multi-location businesses can also now use Chatmeter's Review Generation

Master the Art of Headlines: Join Ann Wylie for a Free Webinar to Boost Press Release Impact!

(NYSE:APO), NEW YORK, Jan. 21, 2025 (GLOBE NEWSWIRE) — WHAT: Webinar – How to Write a Press Release Headline That Works Struggling to make your press release headlines stand out? Join award-winning writing coach Ann Wylie, president of Wylie Communications, for an exclusive webinar packed with proven strategies to craft attention-grabbing headlines that captivate readers,

NeurAxis Announces New Medical Policy Coverage with Molina Healthcare for Over Five Million Lives Across Multiple States

(NYSE MKT:NRXS), CARMEL, Ind., Jan. 21, 2025 (GLOBE NEWSWIRE) — NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults, today announced medical policy coverage for Percutaneous Electrical Nerve Field Stimulation (PENFS), with Molina Healthcare. Molina, with over 40 years

Scroll to Top